1. Academic Validation
  2. Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling

Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling

  • Nat Chem Biol. 2016 May;12(5):373-9. doi: 10.1038/nchembio.2056.
Geoffrey A Smith 1 2 Kenji Uchida 1 Arthur Weiss 2 3 Jack Taunton 1
Affiliations

Affiliations

  • 1 Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California, USA.
  • 2 Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Division of Rheumatology, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
  • 3 Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, California, USA.
Abstract

To drive lymphocyte proliferation and differentiation, common γ-chain (γc) Cytokine Receptors require hours to days of sustained stimulation. JAK1 and JAK3 kinases are found together in all γc-receptor complexes, but how their respective catalytic activities contribute to signaling over time is not known. Here we dissect the temporal requirements for JAK3 kinase activity with a selective covalent inhibitor (JAK3i). By monitoring phosphorylation of the transcription factor STAT5 over 20 h in CD4(+) T cells stimulated with interleukin 2 (IL-2), we document a second wave of signaling that is much more sensitive to JAK3i than the first wave. Selective inhibition of this second wave is sufficient to block cyclin expression and entry to S phase. An inhibitor-resistant JAK3 mutant (C905S) rescued all effects of JAK3i in isolated T cells and in mice. Our chemical genetic toolkit elucidates a biphasic requirement for JAK3 kinase activity in IL-2-driven T cell proliferation and will find broad utility in studies of γc-receptor signaling.

Figures
Products